<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3352BD64-570E-4C5A-B963-474AA0BD3C59"><gtr:id>3352BD64-570E-4C5A-B963-474AA0BD3C59</gtr:id><gtr:name>Division of Computational Biology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1F9A8DF2-2957-4E0A-9A52-06A074C5E460"><gtr:id>1F9A8DF2-2957-4E0A-9A52-06A074C5E460</gtr:id><gtr:name>Biological Sciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Research and Innovation Services</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3352BD64-570E-4C5A-B963-474AA0BD3C59"><gtr:id>3352BD64-570E-4C5A-B963-474AA0BD3C59</gtr:id><gtr:name>Division of Computational Biology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1F9A8DF2-2957-4E0A-9A52-06A074C5E460"><gtr:id>1F9A8DF2-2957-4E0A-9A52-06A074C5E460</gtr:id><gtr:name>Biological Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/70DCA67A-7848-495D-8C3B-5BE43B80C47D"><gtr:id>70DCA67A-7848-495D-8C3B-5BE43B80C47D</gtr:id><gtr:firstName>Angus</gtr:firstName><gtr:otherNames>Iain</gtr:otherNames><gtr:surname>Lamond</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0801738"><gtr:id>049EC80F-8E93-439E-8E5D-E76B849844E8</gtr:id><gtr:title>snoRNA Vectors for Sequence-specific Gene Knockdown in human cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801738</gtr:grantReference><gtr:abstractText>Genes carry the genetic instructions to allow cells to build proteins that control chemical reactions within cells and that regulate cell growth and division. Mutations can cause genes to make defective proteins that in turn cause many forms of human disease, including cancer, diabetes and inherited disorders. This proposal will develop a new technology that allows researchers to control which genes are active in human cells and also allows them to inactivate the defective copies of mutated genes and replace them with new genes that can now make the correct and active form of the same protein. This can be widely used to help test and develop new drugs and may also be developed as a direct therapy for use in patients.</gtr:abstractText><gtr:technicalSummary>This proposal aims to develop, optimize and evaluate a novel technology for the sequence-specific knock-down and replacement of one or multiple targeted genes in mammalian cells. This will provide a new approach for analysing gene function and for evaluating the effects of chemical inhibitors and drugs in human cells. The technology is based upon our recent discovery of a class of human small nucleolar RNAs (Box C/D snoRNAs) that can be targeted to inhibit the expression of cellular mRNAs and their protein products via the introduction of short regions of sequence complementarity within the snoRNA. This is the subject of a UK patent application entitled ?Targeted Modulation of Gene Expression?. The technology promises major advantages over existing methods, including the ability to knock-down two or more targeted genes simultaneously, thereby overcoming problems associated with analysing biological mechanisms involving genetic redundancy. It also provides a way to rapidly knock down one or more targeted genes and simultaneously replace them with a tagged and/or mutated version of the same gene, using a single vector.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-29</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>516076</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Division of Computational Biology</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Barton Group</gtr:department><gtr:description>Bioinformatic analysis of snoRNAs - College of Life Sciences</gtr:description><gtr:id>A51FF193-EBCD-47FD-A36F-AA746C1C4DF3</gtr:id><gtr:impact>There have been three publications published from this work Ono et. al (2011), Ono et. al. (2010) and Scott et. al (2009) with one more paper &amp;quot;Human box C/D snoRNA processing conservation across multiple cell types&amp;quot; Michelle S. Scott1,3*, Motoharu Ono2*, Kayo Yamada2, Akinori Endo2, 4, Geoffrey J. Barton1, Angus I. Lamond2 currently under-review with Nucleic Acids Research</gtr:impact><gtr:partnerContribution>Our collaborators have contributed the bioinformatics to compliment our wet-lab research</gtr:partnerContribution><gtr:piContribution>We initiated the collaboration and carried out all of the 'wet lab' experimental work. Our collaborators carried out computational analyses of snoRNA sequences and other bioinformatic studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Analysis of SUMO modified snoRNA Proteins</gtr:description><gtr:id>AD8F12AF-3EEA-4071-9EA1-BEABEE90B6A5</gtr:id><gtr:impact>This research led to the publication of Westman et. al (2010) with Dr. Edouard Bertrand.</gtr:impact><gtr:partnerContribution>Partners carried out specific experiments to analyse the localisation and RNA binding properties of mutant snoRNA proteins created in my laboratory and provided advice and help with several aspects of the project and experimental design. Co-authored manuscripts.</gtr:partnerContribution><gtr:piContribution>We led the collaboration and carried out the major part of the experimental work, including proteomic analysis of nucleoli isolated from cells expressing His-tagged SUMO1 &amp;amp; SUMO2 as well as mutagenesis and transfection studies to characterise the identified SUMO substrates.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>co-author Geoff Barton</gtr:description><gtr:id>1F6B30B5-E1A2-42EF-8F35-4AFB4D23C7D2</gtr:id><gtr:impact>PMID: 19763159 
PMID: 20219969 
PMID: 20663773 
PMID: 20826608 
PMID: 21247878 
PMID: 21272300 
PMID: 21937730 
PMID: 22199253</gtr:impact><gtr:partnerContribution>co-author</gtr:partnerContribution><gtr:piContribution>Publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>College of Life Sciences</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biological Chemistry and Drug Discovery</gtr:department><gtr:description>Human miRNA precursors with box H/ACA snoRNA features</gtr:description><gtr:id>4A12A683-4085-497D-9526-184902222825</gtr:id><gtr:impact>Publication: Pubmed id 19763159</gtr:impact><gtr:partnerContribution>Bioinformatic analysis carried out by the Barton Group. For their hypothesis experimental work was undertaken.</gtr:partnerContribution><gtr:piContribution>Bioinformatic analysis was done by Michelle Scott and then experiments were performed in the Lamond lab.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Co-author Sonia Rocha</gtr:description><gtr:id>92C2313B-980B-438B-972C-E9E1AEA2E55F</gtr:id><gtr:impact>Publications - 23839046 / 23375502
Patents published</gtr:impact><gtr:partnerContribution>Co-authors</gtr:partnerContribution><gtr:piContribution>Publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Gene Regulation and Expression</gtr:department><gtr:description>co-author Sonia Rocha</gtr:description><gtr:id>AAD15146-4948-41A6-93ED-2AB11D61C111</gtr:id><gtr:impact>Enhanced snoMEN vectors facilitate establishment of GFP-HIF-1a protein replacement human cell lines - to be published in 2016</gtr:impact><gtr:partnerContribution>Co-authors</gtr:partnerContribution><gtr:piContribution>Publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Visit - Fife</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9EAEE34D-4B75-405D-892E-087AB0FE5DA8</gtr:id><gtr:impact>Presentation of research to school children

Positive feedback from schools and being invited back</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in Science Events</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>87F4D408-92E5-44D3-B089-4F3203D41F38</gtr:id><gtr:impact>Good attendance by local public to these events

HIghlighting the opportunities available in science</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Seminar Speaker</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F6F20F56-69F8-4AD2-AEB3-37B3839B85AA</gtr:id><gtr:impact>Presentations of results

Regularly invited as a seminar speaker</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Doors Day at the College of Life Sciences</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1C6F54C4-0120-4C18-BCC7-849232560ACA</gtr:id><gtr:impact>Approx 150-180 members of the public visit the Open Doors Days each year to take part in tours, see exhibits and to ask researchers questions.

The number of visitors to Open Doors Days has been steadily increasing over the last few years</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Open Doors Day (Oranges &amp; Lemons Nursery, Dundee)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0730877F-AB2F-41F8-8B63-6E7272E1B5AB</gtr:id><gtr:impact>Participation in scientific exhibition activity, workshop at this local nursery. Targeted at Primary school children/parents.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of Editorial Board - Science Scotland</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>638A335C-85DA-40E4-91E7-14BD8BCFD010</gtr:id><gtr:impact>Science Scotland is availalble online and is distributed nationwide

Recognised for contribution to Science and asked to contribute an editorial piece</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WT 75th Anniversary Celebrations (Dundee 2011)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B35379B9-227D-4BF6-BAE4-DDEE8B591912</gtr:id><gtr:impact>HIghlighted the good work of the WT, London by hosting this celebration

UoD were asked to host this celebration</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GRE videos</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>795BB637-28BF-4E7A-8EDF-873D80E70556</gtr:id><gtr:impact>The GRE video is available on our website for anyone to view

Positive feedback</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>BBSRC Impact Award</gtr:department><gtr:description>BBSRC Sparking Impact</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>F1E97564-ED0C-4A0F-90AE-B12878A5CB38</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to a method of targeting mi RNA and/or premiRNA molecules in order to treat diseases that are linked with mi RNA expression, such as certain cancers. The present invention also provides modified sno RNA molecules for targeting mi RNA molecules for use in treating diseases that are linked with mi RNA expression, such as certain cancers.</gtr:description><gtr:id>4EC5557A-C53B-4B62-9DEA-CBAD569019BC</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>US2014275221</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>TARGETING OF MIRNA PRECURSORS</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to a method of modulating gene expression using snoRNA molecules or snoRNA like molecules or fragments, designed to target specific nucleic acid sequences.</gtr:description><gtr:id>B8604E48-9A58-430E-A72C-E5F4EC93FC6F</gtr:id><gtr:impact>n/a</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2009037490</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>TARGETED MODULATION OF GENE EXPRESSION</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Dundee Cell Products</gtr:companyName><gtr:description>Dundee Cell Products (DCP) is a spin out company of University of Dundee of which Angus I Lamond is a co-founder. http://www.dundeecellproducts.com/ ; http://www.dundeecellproducts.com</gtr:description><gtr:id>AD6FAEC8-B350-4DA6-B81B-BFB1AF1A6FAF</gtr:id><gtr:impact>1. Dundee Cell Products has successfully commercialised SILAC quantitative proteomics technology to academic and commercial customers. It has carried out SILAC analysis for customers in about six universities and recently gained a service contract with one of the world's largest pharmaceutical companies to apply this technology in their drug discovery and development process. The company has also developed various SILAC ready-to-use tissue culture media that facilitate the culture of cell lines for subsequent quantitative proteomics analysis. These special SILAC media have gained customers all over Europe and in North America. 
2. Since spinout, the company has commercialised life sciences research reagents including antibodies, recombinant proteins, DNA clones, stable cell lines, etc., many of which have been developed or licensed from Universities/academic institutions. 
3. The company has created new jobs by employing five highly skilled staff (3 post-doctoral, two undergraduates). It also provides part-time work to two contractors (bookkeeper and accountant), work to local businesses and outsources some work to the University of Dundee thus providing extra revenue to the institution.</gtr:impact><gtr:url>http://www.dundeecellproducts.com/</gtr:url><gtr:yearCompanyFormed>2006</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76EC4AEE-CBBD-42AA-A806-A1B758C57EFE"><gtr:id>76EC4AEE-CBBD-42AA-A806-A1B758C57EFE</gtr:id><gtr:title>Analysis of human protein replacement stable cell lines established using snoMEN-PR vector.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d441276053f7c2bef52b0266147e7d65"><gtr:id>d441276053f7c2bef52b0266147e7d65</gtr:id><gtr:otherNames>Ono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F689F1E-37DF-4097-989E-3BE7485023CA"><gtr:id>4F689F1E-37DF-4097-989E-3BE7485023CA</gtr:id><gtr:title>Human box C/D snoRNA processing conservation across multiple cell types.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8388dc1edf1938d27c8fbc1a162882b5"><gtr:id>8388dc1edf1938d27c8fbc1a162882b5</gtr:id><gtr:otherNames>Scott MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F6B39FCC-DF54-4182-BE90-638EE92ADF52"><gtr:id>F6B39FCC-DF54-4182-BE90-638EE92ADF52</gtr:id><gtr:title>From snoRNA to miRNA: Dual function regulatory non-coding RNAs.</gtr:title><gtr:parentPublicationTitle>Biochimie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8388dc1edf1938d27c8fbc1a162882b5"><gtr:id>8388dc1edf1938d27c8fbc1a162882b5</gtr:id><gtr:otherNames>Scott MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0300-9084</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E159E776-09E4-417E-93A9-2DDC9789388E"><gtr:id>E159E776-09E4-417E-93A9-2DDC9789388E</gtr:id><gtr:title>Identification of human miRNA precursors that resemble box C/D snoRNAs.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d441276053f7c2bef52b0266147e7d65"><gtr:id>d441276053f7c2bef52b0266147e7d65</gtr:id><gtr:otherNames>Ono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE02D9E9-C6F7-4FA7-A229-F8CA2697E122"><gtr:id>FE02D9E9-C6F7-4FA7-A229-F8CA2697E122</gtr:id><gtr:title>Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9dcd503e15cc82dfb88ce7af18ec9765"><gtr:id>9dcd503e15cc82dfb88ce7af18ec9765</gtr:id><gtr:otherNames>Yamada K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63BE996A-AA68-48B3-879B-C917BD821065"><gtr:id>63BE996A-AA68-48B3-879B-C917BD821065</gtr:id><gtr:title>FMN2 is a novel regulator of the cyclin-dependent kinase inhibitor p21.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9dcd503e15cc82dfb88ce7af18ec9765"><gtr:id>9dcd503e15cc82dfb88ce7af18ec9765</gtr:id><gtr:otherNames>Yamada K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96EE33B1-084C-4456-92F3-C3CA346203AF"><gtr:id>96EE33B1-084C-4456-92F3-C3CA346203AF</gtr:id><gtr:title>Targeted Knock-Down of miR21 Primary Transcripts Using snoMEN Vectors Induces Apoptosis in Human Cancer Cell Lines.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d441276053f7c2bef52b0266147e7d65"><gtr:id>d441276053f7c2bef52b0266147e7d65</gtr:id><gtr:otherNames>Ono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32031117-BA53-429B-B270-125C616F7439"><gtr:id>32031117-BA53-429B-B270-125C616F7439</gtr:id><gtr:title>Enhanced snoMEN Vectors Facilitate Establishment of GFP-HIF-1a Protein Replacement Human Cell Lines.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d441276053f7c2bef52b0266147e7d65"><gtr:id>d441276053f7c2bef52b0266147e7d65</gtr:id><gtr:otherNames>Ono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58C1B660-1B8F-4012-82ED-0DC50EDCDC81"><gtr:id>58C1B660-1B8F-4012-82ED-0DC50EDCDC81</gtr:id><gtr:title>Analysis of human small nucleolar RNAs (snoRNA) and the development of snoRNA modulator of gene expression vectors.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d441276053f7c2bef52b0266147e7d65"><gtr:id>d441276053f7c2bef52b0266147e7d65</gtr:id><gtr:otherNames>Ono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801738</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>